ADGM_OUT_1 [2025-04-28 06:43:20 -0400] 3894 Bytes | 1032 tokens | Cum: 1032 tkns (12.90% of 8k)
==========================================================================

Turbo, you got one job - predict the hottest stocks of the day -- before everyone else does! Ha! So today we're looking at Adagio Medical (ADGM) which is at $1.30 up from $1.14. So, I pulled together a bunch of data for you to look over real fast. It's still early, 6:43 AM on Mon Apr 28, 2025. So, what's the verdict? You're the expert!

--- COMPANY PROFILE ---
Company: Adagio Medical (ADGM)
IPO: 2024-08-01 (9 Months Ago)
Market Cap: $14,200,261
Shares Outstanding: 15,380,000
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange: XNAS
Description: Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.

Here’s a list of headlines for Adagio Medical:

Apr-17-25 08:30AM - Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
Mar-31-25 04:01PM - Adagio Medical Appoints Deborah Kaster as Chief Business Officer
Mar-31-25 04:01PM 08:30AM - Adagio Medical Reports Fourth Quarter and Full Year 2024 Results
Mar-17-25 04:01PM - Adagio Medical Provides Clinical and Business Updates
Feb-28-25 08:30AM - Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation
Feb-18-25 04:01PM - Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference
Dec-16-24 08:00AM - Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director
Nov-14-24 04:01PM - Adagio Medical Reports Third Quarter 2024 Results
Nov-04-24 04:01PM - Adagio Medical to Present at the Stifel 2024 Healthcare Conference
Oct-24-24 08:30AM - Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
Oct-07-24 04:01PM - Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
Aug-19-24 04:01PM - Adagio Medical Provides Business Updates

Prior AI Reports for ADGM:
1. 2025-04-17 – Score: 27 – Target: 1.5000 – Highs: 2.8700 / 1.4900 / 1.39
adagio-medical-faces-challenges-despite-trading-activity-spike

(Note: Highs = Same day / 2nd day / 3rd day)

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Adagio Medical (ADGM).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

ADGM_OUT_3 [2025-04-28 06:43:21 -0400] 934 Bytes | 281 tokens | Cum: 1315 tkns (16.44% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-22T20:05:20Z - Best Small Cap Stocks To Watch Now - April 20th...
A2 - 2025-04-22T17:05:43Z - 12 Health Care Stocks Moving In Tuesday's Intraday Session - Akso Health (NASDAQ:AHG), Adagio Medica...
A3 - 2025-04-21T20:11:06Z - Best Small Cap Stocks To Follow Now - April 19th...
A4 - 2025-04-21T17:05:41Z - 12 Health Care Stocks Moving In Monday's Intraday Session - Annovis Bio (NYSE:ANVS), Adagio Medical ...
A5 - 2025-04-21T14:32:03Z - Why Nano-Cap Adagio Medical Saw The Highest Weekly Spurt In Retail Following Among Healthcare Stocks...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ADGM_OUT_5 [2025-04-28 06:43:21 -0400] 1181 Bytes | 286 tokens | Cum: 1603 tkns (20.04% of 8k)
==========================================================================

Showing A1 (chunk 1 of 8): A1:
**Best Small Cap Stocks To Watch Now - April 20th**Date: 2025-04-22Source: {'uri': 'marketbeat.com', 'dataType': 'news', 'title': 'Market Beat'}URL: https://www.marketbeat.com/instant-alerts/best-small-cap-stocks-to-watch-now-april-20th-2025-04-20/Paragon 28, Adagio Medical, uniQure, JetBlue Airways, and Applied Digital are the five Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small cap stocks refer to shares of companies with relatively small market capitalizations, typically ranging from a few hundred million dollars up to around $2 billion. These stocks are often associated with higher growth potential and volatility compared to larger, more established companies, which can offer both significant opportunities and additional risks for investors. These companies had the highest dollar trading volume of any Small Cap stocks within the last several

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_7 [2025-04-28 06:43:22 -0400] 1181 Bytes | 329 tokens | Cum: 1934 tkns (24.18% of 8k)
==========================================================================

Showing A1 (chunk 2 of 8): days.

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.

Shares of Paragon 28 stock traded up $0.00 during trading hours on Friday, reaching $13.09. 19,380,085 shares of the company's stock were exchanged, compared to its average volume of 1,067,929. Paragon 28 has a 52-week low of $4.65 and a 52-week high of $13.13. The company has a fifty day moving average of $13.03 and a 200-day moving average of $10.59. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. The firm has a

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_9 [2025-04-28 06:43:22 -0400] 1181 Bytes | 325 tokens | Cum: 2261 tkns (28.26% of 8k)
==========================================================================

Showing A1 (chunk 3 of 8): market capitalization of $1.10 billion, a price-to-earnings ratio of -17.69 and a beta of 1.47.

Read Our Latest Research Report on FNA

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.

Adagio Medical stock traded up $0.86 during trading on Friday, hitting $1.78. The company's stock had a trading volume of 115,115,884 shares, compared to its average volume of 859,018. The stock's fifty day moving average is $1.05 and its 200 day moving average is $1.63. The company has a debt-to-equity ratio of 0.18, a quick ratio of 3.90 and a current ratio of 4.42. Adagio Medical has a 1-year low of $0.63 and a 1-year high of $9.34.

Read O

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_11 [2025-04-28 06:43:23 -0400] 1181 Bytes | 329 tokens | Cum: 2592 tkns (32.40% of 8k)
==========================================================================

Showing A1 (chunk 4 of 8): ur Latest Research Report on ADGM

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease.

Shares of NASDAQ QURE traded up $3.61 on Friday, reaching $13.00. 14,440,345 shares of the company traded hands, compared to its average volume of 1,748,885. The stock has a market capitalization of $703.00 million, a PE ratio of -2.62 and a beta of 0.42. uniQure has a fifty-two week low of $3.73 and a fifty-two week high of $19.18. The company has a current ratio of 6.51, a quick ratio of 6.51 and a debt-to-equity ratio of 0.92. The company has a 50 day moving average of $11.89 and a 200 day moving average of $11.28.

Read Ou

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_13 [2025-04-28 06:43:24 -0400] 1181 Bytes | 327 tokens | Cum: 2921 tkns (36.51% of 8k)
==========================================================================

Showing A1 (chunk 5 of 8): r Latest Research Report on QURE

JetBlue Airways Corporation provides air transportation services. The company operates a fleet of Airbus A321, Airbus A220, Airbus A321neo, Airbus A320 Restyled, Airbus A320, Airbus A321 with Mint, Airbus A321neo with Mint, Airbus A321neoLR with Mint, and Embraer E190 aircraft. It also serves 100 destinations across the United States, the Caribbean and Latin America, Canada, and Europe.

JetBlue Airways stock traded up $0.25 during trading on Friday, reaching $3.67. The company had a trading volume of 42,433,896 shares, compared to its average volume of 18,616,114. The company has a debt-to-equity ratio of 3.08, a quick ratio of 1.18 and a current ratio of 1.10. The firm has a market capitalization of $1.30 billion, a price-to-earnings ratio of -1.57 and a beta of 1.69. JetBlue Airways has a 12-month low of $3.34 and a 12-month high of $8.31. The stock's

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_15 [2025-04-28 06:43:24 -0400] 1181 Bytes | 299 tokens | Cum: 3222 tkns (40.27% of 8k)
==========================================================================

Showing A1 (chunk 6 of 8): 50 day moving average price is $5.43 and its two-hundred day moving average price is $6.40.

Read Our Latest Research Report on JBLU

Applied Digital Corporation designs, develops, and operates datacenters in North America. Its datacenters provide digital infrastructure solutions to the high-performance computing industry. The company also provides artificial intelligence cloud services, high performance computing datacenter hosting, and crypto datacenter hosting services.

Shares of NASDAQ APLD traded down $0.14 during trading on Friday, hitting $3.94. 36,300,379 shares of the company traded hands, compared to its average volume of 28,302,324. The firm has a market capitalization of $885.39 million, a P/E ratio of -2.28 and a beta of 5.18. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 1.22. The company has a 50-day moving average price of

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_17 [2025-04-28 06:43:25 -0400] 1181 Bytes | 276 tokens | Cum: 3500 tkns (43.75% of 8k)
==========================================================================

Showing A1 (chunk 7 of 8): $6.78 and a 200-day moving average price of $7.78. Applied Digital has a 1 year low of $2.36 and a 1 year high of $12.48.

Read Our Latest Research Report on APLD

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Paragon 28, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Paragon 28 wasn't on the list.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_19 [2025-04-28 06:43:25 -0400] 407 Bytes | 108 tokens | Cum: 3610 tkns (45.12% of 8k)
==========================================================================

Showing A1 (chunk 8 of 8):

While Paragon 28 currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_21 [2025-04-28 06:43:27 -0400] 1085 Bytes | 285 tokens | Cum: 3897 tkns (48.71% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-02 8-K Item 2.02. Results of Oper and Fin Cond.

On March 31, 2025, Adagio Medical Holdings, Inc. (the Company), issued a press release announcing the Companys financial results for the fiscal year ended December 31, 2024. A copy of this press release is furnished as E...

S2 - 2025-04-02 8-K Item 2.02. Results of Oper and Fin Cond.

On March 31, 2025, Adagio Medical Holdings, Inc. (the Company), issued a press release announcing the Companys financial results for the fiscal year ended December 31, 2024. A copy of this press release is furnished as E...

S3 - 2025-03-27 10-K Item 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper.

The following discussion and analysis of financial condition and results of operations should be read together with the CONS financial statements as of and for the years ended...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ADGM_OUT_23 [2025-04-28 06:43:28 -0400] 1104 Bytes | 269 tokens | Cum: 4168 tkns (52.10% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item 2.02. Results of Operations and Financial Condition.

On March 31, 2025, Adagio Medical Holdings, Inc. (the Company), issued a press release announcing the Companys financial results for the fiscal year ended December 31, 2024. A copy of this press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

The information furnished with this Item 2.02, including Exhibit 99.1, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended (the Securities Act), or the Exchange Act, except as expressly set forth by specific reference in such a filing....

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_25 [2025-04-28 06:43:34 -0400] 6759 Bytes | 1863 tokens | Cum: 6033 tkns (75.41% of 8k)
==========================================================================

This is our set of metrics for Adagio Medical.
Please analyze the numbers.

+--------------------+----------------------+------------------------+-------------------+
| Volume: 608,914 | Perf Month: 39.05% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+--------------------+----------------------+------------------------+-------------------+
| Avg Volume: 2.03M | Perf Quarter: 28.71% | Short Float: 0.47% | ROE: -329.16% |
+--------------------+----------------------+------------------------+-------------------+
| Rel Volume: 0.29 | Index: - | Short Ratio: 0.03 | ROI: -208.25% |
+--------------------+----------------------+------------------------+-------------------+
| RSI (14): 57.96 | Market Cap: 20.00M | Short Interest: 0.07M | Sales Surprise: - |
+--------------------+----------------------+------------------------+-------------------+
| ATR (14): 0.28 | Shs Outstand: 15.20M | Beta: 0.04 | EPS Surprise: - |
+--------------------+----------------------+------------------------+-------------------+
| SMA20: 37.06% | Shs Float: 15.10M | Sales Q/Q: - | P/E: - |
+--------------------+----------------------+------------------------+-------------------+
| SMA50: 23.83% | Inst Own: 70.64% | Sales past 5Y: -25.00% | Earnings: - |
+--------------------+----------------------+------------------------+-------------------+
| SMA200: -57.30% | Insider Own: 1.81% | Employees: 80 | |
+--------------------+----------------------+------------------------+-------------------+
| Perf Week: -26.97% | Insider Trans: 0.00% | Debt/Eq: 0.82 | |
+--------------------+----------------------+------------------------+-------------------+

The next section covers any insider trading by Adagio Medical officers or majority shareholders (if available).

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by Cox James L (Unknown Title) on 2025-03-20
- Non-qualified stock option (right to buy): 90000 shares at $0 (D)
- Non-qualified stock option (right to buy): 364000 shares at $0 (D)

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by GARDINER SANDRA A. (Unknown Title) on 2025-03-20
- Non-qualified stock option (right to buy): 90000 shares at $0 (D)

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by Mirsaeedi-Farahani Keyvan (Unknown Title) on 2025-03-20
- Non-qualified stock option (right to buy): 90000 shares at $0 (D)

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by MISHAN ORLY (Unknown Title) on 2025-03-20
- Non-qualified stock option (right to buy): 300000 shares at $0 (D)

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by Moran Timothy P. (Unknown Title) on 2025-03-20
- Non-qualified stock option (right to buy): 90000 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 602000, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -64132199.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.3
Average Volume: 6414069.0
30-Day High: 1.78
30-Day Low: 0.7407

[Detailed Financials: TTM 2024]
- Total Assets: $48,448,000.00
- Total Liabilities: $28,536,000.00
- Total Equity: $19,912,000.00
- Current Assets: $25,349,000.00
- Current Liabilities: $7,763,000.00

[Income Statement: TTM 2024]
- Revenue: $602,000.00
- Net Income: $-64,132,199.00
- Gross Profit: $-2,716,000.00
- Operating Income: $-84,160,000.00
- Earnings Per Share (EPS): -2134210.72

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-725,000.00

[Detailed Financials: FY 2024]
- Total Assets: $48,448,000.00
- Total Liabilities: $28,536,000.00
- Total Equity: $19,912,000.00
- Current Assets: $25,349,000.00
- Current Liabilities: $7,763,000.00

[Income Statement: FY 2024]
- Revenue: $602,000.00
- Net Income: $-64,132,199.00
- Gross Profit: $-2,716,000.00
- Operating Income: $-84,160,000.00
- Earnings Per Share (EPS): -2134210.72

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-725,000.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Adagio Medical (ADGM).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Adagio Medical.

2) MARKET_SCORE[]
This conversation was initiated because ADGM is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for ADGM.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, ADGM could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect ADGM to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Adagio Medical.

11) ETHICAL_RATING[]
Rate Adagio Medical’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Adagio Medical.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

ADGM_IN_27 [2025-04-28 06:43:34 -0400] 126 Bytes | 29 tokens | Cum: 6259 tkns (78.24% of 8k)
==========================================================================

====================================
[2025-04-28 06:43:34] # Analysis Completed
Elapsed Time: 15.15 seconds